Targeting cardiovascular inflammation: next steps in clinical translation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting cardiovascular inflammation: next steps in clinical translation
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-02-04
DOI
10.1093/eurheartj/ehaa099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure
- (2019) Brendan M. Everett et al. CIRCULATION
- Immunity and Inflammation in Atherosclerosis
- (2019) Dennis Wolf et al. CIRCULATION RESEARCH
- Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome
- (2019) Preethi Mani et al. JAMA Cardiology
- Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Survival in Sepsis
- (2019) Michael C. Sklar et al. CRITICAL CARE MEDICINE
- Anticytokine Agents
- (2019) Paul M Ridker CIRCULATION RESEARCH
- Novel Antiatherosclerotic Therapies
- (2019) Peter Libby et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- REDUCE-IT
- (2019) Deepak L Bhatt EUROPEAN HEART JOURNAL
- Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
- (2019) Deepak L Bhatt et al. LANCET
- THEMIS and THEMIS-PCI
- (2019) Deepak L Bhatt et al. EUROPEAN HEART JOURNAL
- Ticagrelor in Patients with Stable Coronary Disease and Diabetes
- (2019) P. Gabriel Steg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acceptability of financial incentives for maintenance of weight loss in mid-older adults: a mixed methods study
- (2018) Bronwyn McGill et al. BMC PUBLIC HEALTH
- Addressing Acute Coronary Syndromes
- (2018) Filippo Crea et al. CIRCULATION
- Inflammatory and Cholesterol Risk in the FOURIER Trial
- (2018) Erin A. Bohula et al. CIRCULATION
- Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy
- (2018) Aruna D. Pradhan et al. CIRCULATION
- Emerging Role of Precision Medicine in Cardiovascular Disease
- (2018) Jane A. Leopold et al. CIRCULATION RESEARCH
- Glycomics and Cardiovascular Disease
- (2018) Patrick R. Lawler CIRCULATION RESEARCH
- C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up
- (2018) Maarten Vanhaverbeke et al. CLINICAL CARDIOLOGY
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
- (2018) Paul M Ridker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
- (2018) Brendan M. Everett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Taming Immune and Inflammatory Responses to Treat Atherosclerosis ∗
- (2018) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Integration of multi-omics data and deep phenotyping enables prediction of cytokine responses
- (2018) Olivier B. Bakker et al. NATURE IMMUNOLOGY
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
- (2018) Raul G. Nogueira et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
- (2018) Neil M Davies et al. BMJ-British Medical Journal
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
- (2018) Neil M Davies et al. BMJ-British Medical Journal
- Arguing for Adaptive Clinical Trials in Sepsis
- (2018) Victor B. Talisa et al. Frontiers in Immunology
- Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels
- (2018) Daniel H. Solomon et al. ANNALS OF INTERNAL MEDICINE
- Heterogeneity and phenotypic stratification in acute respiratory distress syndrome
- (2018) Patrick R Lawler et al. Lancet Respiratory Medicine
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
- (2018) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease
- (2017) T.P. Singh et al. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
- Interleukin-1 Beta as a Target for Atherosclerosis Therapy
- (2017) Peter Libby JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
- (2017) Claes Held et al. Journal of the American Heart Association
- Trends in Total Cholesterol, Triglycerides, and Low-Density Lipoprotein in US Adults, 1999-2014
- (2017) Asher Rosinger et al. JAMA Cardiology
- The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation
- (2017) Milan Pavlović et al. Scientific Reports
- Host and Environmental Factors Influencing Individual Human Cytokine Responses
- (2016) Rob ter Horst et al. CELL
- Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to Pathogens
- (2016) Yohann Nédélec et al. CELL
- Glycosylation Signatures of Inflammation Identify Cardiovascular Risk
- (2016) Patrick R. Lawler et al. CIRCULATION RESEARCH
- Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality RiskNovelty and Significance
- (2016) Patrick R. Lawler et al. CIRCULATION RESEARCH
- The Biological Basis for Cardiac Repair After Myocardial Infarction
- (2016) Sumanth D. Prabhu et al. CIRCULATION RESEARCH
- From C-Reactive Protein to Interleukin-6 to Interleukin-1
- (2016) Paul M Ridker CIRCULATION RESEARCH
- Anti-inflammatory treatment of acute coronary syndromes: the need for precision medicine
- (2016) Filippo Crea et al. EUROPEAN HEART JOURNAL
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
- (2016) Ola Kleveland et al. EUROPEAN HEART JOURNAL
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
- (2016) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adaptive Immunity Dysregulation in Acute Coronary Syndromes
- (2016) Davide Flego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Test in Context
- (2016) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Precision medicine in cardiology
- (2016) Elliott M. Antman et al. Nature Reviews Cardiology
- Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease
- (2016) Gerard Pasterkamp et al. Nature Reviews Cardiology
- Adaptive Designs for Clinical Trials
- (2016) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trained immunity: A program of innate immune memory in health and disease
- (2016) M. G. Netea et al. SCIENCE
- Interleukin-1 in Stroke
- (2016) Oluwaseun A. Sobowale et al. STROKE
- Not all plaque ruptures are born equal: an optical coherence tomography study
- (2016) Giancarla Scalone et al. European Heart Journal-Cardiovascular Imaging
- Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction
- (2016) Vibeke N. Ritschel et al. Journal of the American Heart Association
- Individual gene expression and personalised medicine in sepsis
- (2016) Jean-Louis Vincent Lancet Respiratory Medicine
- The Platform Trial
- (2015) Scott M. Berry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Time-Dependent Changes in Atherosclerotic Plaque Composition in Patients Undergoing Carotid Surgery
- (2014) Guus W. van Lammeren et al. CIRCULATION
- Critical appraisal of inflammatory markers in cardiovascular risk stratification
- (2014) Magdalena Krintus et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
- (2014) A. C. Morton et al. EUROPEAN HEART JOURNAL
- The inflammatory response in myocardial injury, repair and remodelling
- (2014) Nikolaos G. Frangogiannis Nature Reviews Cardiology
- Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
- (2014) E. Choy et al. RHEUMATOLOGY
- Why have clinical trials in sepsis failed?
- (2014) John C. Marshall TRENDS IN MOLECULAR MEDICINE
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Targeting inflammatory pathways in myocardial infarction
- (2013) Panagiota Christia et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy
- (2013) Wolfgang Koenig INTERNATIONAL JOURNAL OF CARDIOLOGY
- High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction
- (2013) Sergio Raposeiras Roubín et al. Revista Portuguesa de Cardiologia
- Inflammation in Atherosclerosis
- (2012) Peter Libby ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Regulation of the Inflammatory Response in Cardiac Repair
- (2012) Nikolaos G. Frangogiannis CIRCULATION RESEARCH
- High Sensitivity C-Reactive Protein and Outcomes Following Percutaneous Coronary Intervention in Contemporary Practice
- (2012) Joerg Herrmann et al. Circulation-Cardiovascular Interventions
- Trends in Lipids and Lipoproteins in US Adults, 1988-2010
- (2012) Margaret D. Carroll et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial
- (2011) P. S. Sever et al. EUROPEAN HEART JOURNAL
- High-Sensitivity C-Reactive Protein Is Within Normal Levels at the Very Onset of First ST-Segment Elevation Acute Myocardial Infarction in 41% of Cases
- (2011) Nicole Cristell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Progress and challenges in translating the biology of atherosclerosis
- (2011) Peter Libby et al. NATURE
- Níveis de PCR são maiores em pacientes com síndrome coronariana aguda e supradesnivelamento do segmento ST do que em pacientes sem supradesnivelamento do segmento ST
- (2010) Syed Shahid Habib et al. Arquivos Brasileiros de Cardiologia
- Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 Trial
- (2010) Benjamin M. Scirica et al. EUROPEAN HEART JOURNAL
- Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes
- (2010) Christophe A. Wyss et al. EUROPEAN HEART JOURNAL
- Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies
- (2010) L.-p. He et al. HEART
- Multiple Biomarkers at Admission Significantly Improve the Prediction of Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
- (2010) Peter Damman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- C-reactive protein improves risk prediction in patients with acute coronary syndromes
- (2009) F. Schiele et al. EUROPEAN HEART JOURNAL
- Trends in High Levels of Low-Density Lipoprotein Cholesterol in the United States, 1999-2006
- (2009) Elena V. Kuklina JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic Value of Biomarkers During and After Non–ST-Segment Elevation Acute Coronary Syndrome
- (2009) Kai M. Eggers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Differential Impact of Admission C-Reactive Protein Levels on 28-Day Mortality Risk in Patients With ST-Elevation Versus Non–ST-Elevation Myocardial Infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry)
- (2008) Bernhard Kuch et al. AMERICAN JOURNAL OF CARDIOLOGY
- Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease
- (2008) Ramón Arroyo-Espliguero et al. ATHEROSCLEROSIS
- Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular Death
- (2008) B. M. Scirica et al. CLINICAL CHEMISTRY
- Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study
- (2008) R. J. Glynn et al. CLINICAL CHEMISTRY
- Clinical Utility of C-Reactive Protein Measured at Admission, Hospital Discharge, and 1 Month Later to Predict Outcome in Patients With Acute Coronary Disease
- (2008) Peter Bogaty et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rosuvastatin in Older Patients with Systolic Heart Failure
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes
- (2007) Stefanos G. Foussas et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started